R&G PharmaStudies Co., Ltd. (SHE:301333)
70.01
-0.63 (-0.89%)
Jan 22, 2026, 4:00 PM EST
48.39% (1Y)
| Market Cap | 6.66B |
| Revenue (ttm) | 789.45M |
| Net Income (ttm) | 151.37M |
| Shares Out | 95.14M |
| EPS (ttm) | 1.59 |
| PE Ratio | 43.99 |
| Forward PE | 44.73 |
| Dividend | 0.16 (0.23%) |
| Ex-Dividend Date | Jul 8, 2025 |
| Volume | 1,996,380 |
| Average Volume | 3,418,580 |
| Open | 70.71 |
| Previous Close | 70.64 |
| Day's Range | 69.59 - 70.97 |
| 52-Week Range | 40.99 - 91.78 |
| Beta | 0.58 |
| RSI | 54.93 |
| Earnings Date | Mar 28, 2026 |